InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-12.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Nolan Sean P., 董事. Director active across 3 companies, notably Taysha Gene Therapies, Inc.. Cumulatively, 12 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €942k. History available since 20 May 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nolan Sean P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,047 股@ US$90.350.0004% mcap32.8% 占其流量Common StockSEC:0001569926-26-000012:0
136,789 股@ US$4.75100.0% 占其流量Common StockSEC:0001569926-26-000008:0
1,008,000 股0Common StockSEC:0001569926-26-000002:0
2,882 股@ US$64.1817.1% 占其流量Common StockSEC:0000740260-25-000175:0
892,500 股0Common StockSEC:0001415889-25-000599:0
3,648 股@ US$47.9616.7% 占其流量Common StockSEC:0000740260-24-000162:0
1,184,688 股0Common StockSEC:0001209191-24-000807:0
444,444 股@ US$0.9089.6% 占其流量Common StockSEC:0001209191-23-046150:0
标准退出：2023年11月14日 (T+90)
3,835 股@ US$45.6316.6% 占其流量Common StockSEC:0000740260-23-000123:0
3,056 股@ US$57.250.0004% mcap34.4% 占其流量Common StockSEC:0000740260-22-000111:0
3,158 股0Common StockSEC:0000740260-21-000134:0
1,170 股@ US$22.355.5% 占其流量Common StockSEC:0001209191-21-035165:0
标准退出：2021年8月18日 (T+90)
12 条申报中的 12 条
About Nolan Sean P.
Nolan Sean P. is Administrateur and has 12 filings in total. Across the 12 sampled filings, the activity runs from 2021-05-24 to 2026-05-15, with EUR 389209 of purchases and EUR 552760 of sales. The main filings concern Taysha Gene Therapies, Inc. and Ventas, Inc., and the modal transaction nature is Attribution.
